Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
04/1992
04/15/1992CN1060292A Process for preparing nontoxic protein by puffing castor-bean dregs for detoxication
04/14/1992US5104976 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein
04/14/1992US5104973 Method for purifying and isolating carboxyl-terminal peptides
04/13/1992CA2053366A1 Azido-substituted fatty acid analog enzyme substrates
04/10/1992CA2052486A1 Protein for inhibiting collagen-stimulated platelet aggregation
04/08/1992EP0479086A2 Teicoplanin recovery process
04/08/1992EP0478689A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1 MN? gp 120
04/08/1992EP0478659A1 Interferon purification process.
04/08/1992CN1060112A Human c3b/c4b receptor (cr1)
04/07/1992US5102995 Dna encoding modified heparin cofactor ii
04/07/1992US5102990 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
04/07/1992US5102989 Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
04/07/1992US5102988 Of human fibronectin
04/07/1992US5102987 Preparation of hydrolyzed protein having reduced α-chlorohydrin content
04/07/1992US5102986 Method for carrying out organic chemical reactions and appartaus for carrying out that method
04/07/1992US5102985 Oxidation of cysteine containing polypeptide with hydorgen peroxide
04/07/1992US5102807 Inhibin isolated from ovarian follicular fluid
04/07/1992US5102524 Multiple electrophoresis device for the controlled migration of macromolecules through rectangular gel plates
04/07/1992CA1298458C Apparatus for processing fluids
04/02/1992WO1992005271A1 Process for the preparation of c-terminally amidated peptides
04/02/1992WO1992005256A1 Natural killer stimulatory factor
04/02/1992WO1992005254A1 Novel neurothrophic factor
04/02/1992WO1992005197A1 Purification of cytokeratin fragments
04/02/1992WO1992005196A1 Aids therapy and vaccine
04/02/1992WO1992005184A1 A non-mitogenic competitive hgf antagonist
04/02/1992WO1992004970A1 Improved tangential filtration process and apparatus
04/02/1992WO1992004914A1 Design of bioactive peptides based on immunoglobulin structure
04/02/1992WO1991009872A3 Hiv-1 env fragment fusion protein
04/02/1992CA2091258A1 Design of bioactive peptides based on immunoglobulin structure
04/02/1992CA2069507A1 Aids therapy and vaccine
04/01/1992EP0478450A1 Method of rapid sequencing of linear and ordered biological sequences
04/01/1992EP0478272A2 Gp98 cell adhesion molecule and integrin complex containing it
04/01/1992EP0477912A2 Novel N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
04/01/1992EP0477508A1 Improved oligosaccharide conjugate vaccines
04/01/1992EP0477345A1 Respiratory burst suppression factor
04/01/1992CN2100393U Universal polypeptide synthesizer
03/1992
03/31/1992US5101059 Xanthene compounds
03/31/1992US5101039 Azabicycloamino carboxylic acid intermediates
03/31/1992US5101018 Somatotropin, Amine Salt or Quaternary Ammonium Salt
03/31/1992US5101013 Such as those obtained by enzymatic cleavage of proinsulin, ion exchanging
03/31/1992US5100873 Bombesin antagonist, anticancer agents, oligopeptides
03/31/1992US5100788 Method of producing and isolating igg-binding protein a fusion peptides and a vector therefor
03/31/1992US5100592 Heated rotary spreaders, two feed streams, melting and coating powders
03/31/1992CA1298435C Pentapeptides with cell growth regulatory effects and a process for the preparation thereof
03/31/1992CA1298434C Process for the preparation of alpha-l-aspartyl-l- phenylalanine methyl ester
03/31/1992CA1298433C Amino acid derivatives
03/31/1992CA1298432C PROCESS FOR SEPARATION OF N-PROTECTED- .alpha. L-ASPARTYL- L-PHENYLALANINES
03/31/1992CA1298219C Homogeneous immune interferon fragment
03/29/1992WO1992006217A1 Method for fast sequencing of linear and ordered biological sequences
03/29/1992WO1992006113A2 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT
03/29/1992CA2092827A1 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
03/29/1992CA2092432A1 Method for fast sequencing of linear and ordered biological sequences
03/28/1992WO1992005804A1 Chelating agents
03/28/1992CA2092434A1 Chelating agents
03/25/1992EP0476983A1 Vascular endothelial cell growth factor II
03/25/1992EP0476875A2 Process for the purification and concentration of biologically active materials
03/25/1992EP0476408A1 Chemical conjugation of morpholino anthracyclines to antibodies
03/25/1992EP0476199A1 Process to isolate phosphopeptides
03/25/1992EP0476038A1 Chemical products.
03/25/1992EP0476015A1 Recombinant alzheimer's amyloid protein
03/25/1992EP0476014A1 Very large scale immobilized polymer synthesis.
03/25/1992CN1059729A Polypeptide compound and process for preparation thereof
03/25/1992CA2051749A1 Cell adhesion molecule
03/24/1992US5098924 Hypotensive agents and angiotensin II inhibitors
03/24/1992US5098888 Cholinergic agents and antispasmodic agents
03/24/1992US5098887 Angiotensin converting enzyme inhibitor
03/24/1992US5098829 Immunoadsorbents
03/24/1992CA1298035C Antitumor amino acid and peptide derivatives of 1,4- bis¬(aminoalkyl andhydroxyaminoalkyl)amino|-5, 8-dihydroxyanthraquinones
03/24/1992CA1298034C Amino acid derivatives
03/24/1992CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin
03/24/1992CA1297816C Platelet function inhibiting monoclonal antibody fragment
03/24/1992CA1297813C Process for production of insulin-like growth factor i
03/22/1992CA2051796A1 Vascular endothelial cell growth factor ii
03/20/1992WO1992004911A1 Substantially pure interleukin-9 receptor and uses thereof
03/19/1992WO1992004625A1 Protein separation by sds electrophoresis in a homogenous gel using a tris-formiate-taurinate buffer system and suitable homogenous electrophoresis plates therefor
03/19/1992WO1992004446A1 Cloning of chicken anaemia dna
03/19/1992WO1992004384A1 Polyethylene glycol derivatives for solid-phase applications
03/19/1992WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
03/19/1992WO1992004366A1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material
03/19/1992EP0484508A4 Proteinaceous fat substitute.
03/18/1992WO1992005191A1 Fungicidally active compounds
03/18/1992WO1992004971A1 Cationic charge modified microporous membranes
03/18/1992EP0475927A2 Method of somatotropin naturation
03/18/1992EP0475779A1 Process for the separation of proteins, polypeptides or metals using immobilized, optionally modified, phosvitin
03/18/1992EP0475719A2 Platelet derived growth regulating peptide
03/18/1992EP0475657A2 Pentapeptide and salts thereof having specific inhibiting effect of epidermal cell proliferation
03/18/1992EP0475553A2 Life span determining protein and method of isolating the same
03/18/1992EP0475311A1 Process for removing proteins originating from Escherichia coli
03/18/1992EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP)
03/18/1992EP0475290A1 A novel biologically active peptide derived from frog (frog CNP)
03/18/1992EP0475230A1 Methods of conjugating actinomycin D
03/18/1992EP0475184A1 Process for the production of peptides by solid phase synthesis
03/18/1992EP0474979A1 Heparin binding neurotrophic factor gene sequence
03/18/1992EP0474789A1 Cysteine thiol-protected peptides for use in immunoassays
03/18/1992EP0474645A1 Protein complex
03/18/1992EP0216786B1 Purification, production and use of tumor necrosis factors
03/18/1992CA2091905A1 Fungicidally active compounds
03/18/1992CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies
03/17/1992US5097060 Adjusting the initial concentration and cooling through conductive heat transfer without forced flow
03/17/1992US5097014 Chromogenic tripeptides